
watch now
Nutritional needs for users of GLP-1 drugs are 'shifting', Nestle CEO says
Nestle CEO Mark Schneider discusses the impact of GLP-1 drugs on the food industry and the company's products that are tailored to users of the drugs.
03:38
Thu, May 30 20245:44 AM EDT
